granted
on 02 May 2024
Last Applicant/ Owned by
500 airview Ave N
Seattle
WA
98109
Serial Number
90173877 filed on 11th Sep 2020
Registration Number
N/A
Correspondent Address
Joi A. White Carr & errell LLP
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical research and development; development of pharmaceutical preparations and drugs; scientific research and development, scientific laboratory services, medical and scientific research, biotechnology research and synthetic biology research, all of the foregoing relating to human beings; development of pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseaseRead More
Medical services
11th 000101
11th 000101
Pharmaceutical research and development; development of pharmaceutical preparations and drugs; scientific research and development, scientific laboratory services, medical and scientific research, biotechnology research and synthetic biology research, all of the foregoing relating to human beings; development of pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders; development of pharmaceutical preparations and drugs in the field of immunotherapy; development of pharmaceutical preparations and drugs in the field of cell therapy; development of pharmaceutical preparations and drugs in the field of gene therapy
11th 000101
11th 000101
Pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders; Cells for medical or clinical purposes; viral or non-viral delivery vectors for medical or clinical purposes; proteins for medical or clinical purposes; pharmaceutical preparations for cell therapy for medical or clinical purposes; pharmaceutical preparations for gene therapy for medical or clinical purposes; kits comprised of cells and pharmaceutical preparations for medical or clinical purposes, namely, for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders; kits comprised of gene delivery vectors and pharmaceutical preparations for medical or clinical purposes, namely, for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders; kits comprised of proteins and pharmaceutical preparations for medical or clinical purposes, in particular for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders
11th 000101
11th 000101
No 90173877
No Service Mark
No T-4821 US
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 03rd May 2024 | NOTICE O APPROVAL O EXTENSION REQUEST E-MAILE |
| 02th May 2024 | SOU TEAS EXTENSION RECEIVE |
| 02th May 2024 | SOU EXTENSION 5 ILE |
| 02th May 2024 | SOU EXTENSION 5 GRANTE |
| 08th Nov 2023 | NOTICE O APPROVAL O EXTENSION REQUEST E-MAILE |
| 06th Nov 2023 | SOU EXTENSION 4 GRANTE |
| 06th Nov 2023 | SOU EXTENSION 4 ILE |
| 06th Nov 2023 | SOU TEAS EXTENSION RECEIVE |
| 04th May 2023 | NOTICE O APPROVAL O EXTENSION REQUEST E-MAILE |
| 02th May 2023 | SOU EXTENSION 3 GRANTE |
